QCLS EBITDA | Q/C Technologies, Inc.

Q/C Technologies, Inc. (QCLS) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$6.79M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$1.86M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$1.79M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$1.87M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2013-03-31 to 2020-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$6.79M	(m)	(m)	(m)	(m)	-$1.82M*	(m)	$236.13K	(m)	(m)
2026-03-31	Reported	(m)	-$1.86M	(m)	(m)	(m)	(m)	-$3.29M	(m)	$510.53K	(m)	(m)
2025-09-30	Reported	(m)	-$1.79M	(m)	(m)	(m)	(m)	-$1.16M*	(m)	$356.35K	(m)	(m)
2025-06-30	Reported	(m)	-$1.87M	(m)	(m)	(m)	(m)	-$2.07M*	(m)	$873.47K	(m)	(m)
2025-03-31	Reported	(m)	-$2.47M	(m)	(m)	(m)	(m)	-$2.64M	(m)	$1.55M	(m)	(m)
2024-09-30	Reported	(m)	-$1.83M	(m)	(m)	(m)	(m)	-$2.43M*	(m)	$707.75K	(m)	(m)
2024-06-30	Reported	(m)	-$3.37M	(m)	(m)	(m)	(m)	-$2.67M*	(m)	$401.10K	(m)	(m)
2024-03-31	Reported	(m)	-$2.78M	(m)	(m)	(m)	(m)	-$1.76M	(m)	$1.20M	(m)	(m)
2023-09-30	Reported	(m)	-$3.84M	(m)	(m)	(m)	(m)	-$3.16M*	(m)	$1.91M	(m)	(m)
2023-06-30	Reported	(m)	-$5.78M	(m)	(m)	(m)	(m)	-$3.92M*	(m)	$2.22M	(m)	(m)
2023-03-31	Reported	(m)	-$2.59M	(m)	(m)	(m)	(m)	-$3.97M	(m)	$770.43K	(m)	(m)
2022-09-30	Reported	(m)	-$3.71M	(m)	(m)	(m)	(m)	-$15.96M*	(m)	$1.80M	(m)	(m)
2022-06-30	Reported	(m)	-$3.64M	(m)	(m)	(m)	(m)	$8.30M*	(m)	$2.16M	(m)	(m)
2022-03-31	Reported	(m)	-$4.12M	(m)	(m)	(m)	(m)	-$2.37M	(m)	$2.63M	(m)	(m)
2021-09-30	Reported	(m)	-$4.41M	(m)	(m)	(m)	(m)	-$6.45M*	(m)	$2.98M	(m)	(m)
2021-06-30	Reported	(m)	-$18.28M	(m)	(m)	(m)	(m)	-$6.75M*	(m)	$1.66M	(m)	(m)
2021-03-31	Reported	(m)	-$3.09M	(m)	(m)	(m)	(m)	-$1.51M	(m)	$1.35M	(m)	(m)
2020-12-31	Reported	-$4.29M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	-$3.24M*	-$3.24M	$1.04K*	(m)	(m)	(m)	-$1.29M*	(m)	$1.74M	(m)	(m)
2020-06-30	Reported	-$1.08M*	-$1.09M	$11.94K*	-$1.89K	57360.54%*	(m)	-$163.10K*	$377.17K	$1.92M	(m)	(m)
2020-03-31	Reported	-$3.53M	(m)	(m)	(m)	-970.71%	(m)	-$1.97M	$172.87K	$2.48M	(m)	(m)
2019-12-31	Reported	-$671,130.00	(m)	(m)	(m)	-843.29%	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$836,220.00	(m)	(m)	(m)	-198.72%	(m)	-$962.23K*	$285.51K	$57.50K	(m)	(m)
2019-06-30	Reported	-$802.17K*	-$821.71K	$19.54K*	$464.51K	-172.69%*	(m)	-$861.62K*	$219.86K	$60.91K	(m)	(m)
2019-03-31	Reported	-$924,565.00	(m)	(m)	(m)	-151.04%	(m)	-$748.74K	$245.94K	$88.39K	(m)	(m)
2018-12-31	Reported	-$2.87M	(m)	(m)	(m)	-1026.47%	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	-$3.06M*	-$3.12M	$60.14K*	$557.09K	-550.03%*	$30.52K*	-$2.05M*	$476.45K	$160.87K	(m)	(m)
2018-06-30	Reported	-$2.06M*	-$2.11M	$56.45K*	$526.60K	-390.57%*	-$129.00*	-$2.02M*	$302.83K	$259.12K	(m)	(m)
2018-03-31	Reported	-$1.84M	(m)	(m)	(m)	-607.32%	$37.83K	-$1.80M	$297.50K	$439.97K	(m)	(m)
2017-12-31	Reported	-$3.19M	(m)	(m)	(m)	-339.42%	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	-$1.12M*	-$1.18M	$61.48K*	$675.83K	-165.14%*	$0.00*	-$1.06M*	$323.53K	$290.45K	(m)	(m)
2017-06-30	Reported	-$760.00K*	-$820.66K	$60.66K*	$1.07M	-70.84%*	$20.42K*	-$1.03M*	$290.59K	$290.84K	(m)	(m)
2017-03-31	Reported	-$1.3M	(m)	(m)	(m)	-202.34%	$16.77K	-$1.56M	$258.72K	$348.44K	(m)	(m)
2016-12-31	Reported	-$1.03M	(m)	(m)	(m)	-158.28%	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	$409.30K*	$301.26K	$108.04K*	(m)	(m)	$6.56K*	-$1.12M*	(m)	$247.58K	(m)	(m)
2016-06-30	Reported	-$957.38K*	-$1.01M	$57.43K*	(m)	(m)	-$2.31K*	(m)	(m)	$321.99K	(m)	(m)
2016-03-31	Reported	-$1.46M	(m)	(m)	(m)	-197.89%	$83.77K	(m)	(m)	$363.29K	(m)	(m)
2015-12-31	Reported	-$3.8M	(m)	(m)	(m)	-811.15%	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$2.26M*	-$2.35M	$80.58K*	(m)	(m)	$15.74K*	(m)	(m)	$319.65K	(m)	(m)
2015-06-30	Reported	-$2.04M*	-$2.12M	$80.58K*	(m)	(m)	-$1.00*	(m)	(m)	$378.23K	(m)	(m)
2015-03-31	Reported	-$1.28M	(m)	(m)	(m)	-250.93%	$44.51K	(m)	(m)	$305.57K	(m)	(m)
2014-12-31	Reported	-$844,612.00	(m)	(m)	(m)	-58.38%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$1.05M*	-$1.14M	$87.88K*	(m)	(m)	$23.33K*	(m)	(m)	$183.89K	(m)	$0.00
2014-06-30	Reported	-$428.68K*	-$515.50K	$86.82K*	(m)	(m)	$1.66K*	(m)	(m)	$248.95K	(m)	$0.00
2014-03-31	Reported	-$526,540.00	(m)	(m)	(m)	-44.85%	$0.00	(m)	(m)	$253.54K	(m)	$0.00
2013-12-31	Reported	-$692,220.00	(m)	(m)	(m)	-121.13%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$455.67K*	-$545.18K	$89.51K*	(m)	(m)	$28.89K*	(m)	(m)	$233.85K	(m)	$0.00
2013-06-30	Reported	-$364.69K*	-$452.83K	$88.14K*	(m)	(m)	$63.11K*	(m)	(m)	$274.42K	(m)	$0.00
2013-03-31	Reported	$56,259.00	(m)	(m)	(m)	3.55%	$7.73K	(m)	(m)	$247.72K	(m)	$0.00

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$9.85M	(m)	(m)	(m)	(m)	-$9.07M	(m)	$3.47M	(m)	(m)
2024-12-31	Reported	(m)	-$10.17M	(m)	(m)	(m)	(m)	-$8.98M	(m)	$3.44M	(m)	(m)
2023-12-31	Reported	(m)	-$17.12M	(m)	(m)	(m)	(m)	-$12.98M	(m)	$7.87M	(m)	(m)
2022-12-31	Reported	(m)	-$15.28M	(m)	(m)	(m)	(m)	-$12.27M	(m)	$9.07M	(m)	(m)
2021-12-31	Reported	(m)	-$28.81M	(m)	(m)	(m)	(m)	-$19.52M	(m)	$6.75M	(m)	(m)
2020-12-31	Reported	-$9.46M	(m)	(m)	(m)	(m)	(m)	-$4.66M	(m)	$2.47M	(m)	(m)
2019-12-31	Reported	-$3.4M	(m)	(m)	(m)	-215.47%	(m)	-$3.07M	$1.10M	$276.79K	(m)	(m)
2018-12-31	Reported	-$9.83M	(m)	(m)	(m)	-589.94%	$68.21K	-$8.50M	$1.54M	$1.06M	(m)	(m)
2017-12-31	Reported	-$6.36M	(m)	(m)	(m)	-189.70%	$54.51K	-$5.08M	$2.41M	$1.26M	(m)	(m)
2016-12-31	Reported	-$3.04M	(m)	(m)	(m)	-102.75%	$123.30K	-$4.17M	(m)	$1.19M	(m)	(m)
2015-12-31	Reported	-$9.38M	(m)	(m)	(m)	-443.59%	$112.95K	(m)	(m)	$1.41M	(m)	-$269.34K
2014-12-31	Reported	-$2.85M	(m)	(m)	(m)	-64.48%	$24.99K	(m)	(m)	$916.31K	(m)	(m)
2013-12-31	Reported	-$1.46M	(m)	(m)	(m)	-40.70%	$123.13K	(m)	(m)	$1.01M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Cardio Diagnostics Holdings, Inc. (CDIO)	United States	$0.006B
BIOMERICA INC (BMRA)	United States	$0.011B
VOLITIONRX LTD (VNRX)		$0.003B	-0.64
IMMUCELL CORP /DE/ (ICCC)	United States	$0.091B	116.10
Insight Molecular Diagnostics Inc. (IMDX)	United States	$0.129B	-3.90
MYRIAD GENETICS INC (MYGN)	United States	$0.397B	-4.84
Alpha Teknova, Inc. (TKNO)	United States	$0.500B	-18.12
QuidelOrtho Corp (QDEL)	United States	$0.733B	-0.90
ACHIEVE LIFE SCIENCES, INC. (ACHV)	United States	$0.806B	-5.88
Intellia Therapeutics, Inc. (NTLA)	United States	$1.705B	-5.92